Welcome! You are invited to join a webinar: Yale Interventional Psychiatry Grand Rounds: Ketamine and Esketamine – Is There a Meaningful Clinical Difference?. After registering, you will receive a confirmation email about joining the webinar.

Speaker: Samuel Wilkinson, MD Associate Professor of Psychiatry Yale School of Medicine Activity Directors: Robert Ostroff, MD Sina Nikayin, MD Objectives: 1. To learn the fundamental biological differences between ketamine and esketamine 2. To learn the different ways these drugs are regulated in psychiatry 3. To learn the evidence that has compared the two therapies Disclosures: The Yale School of Medicine implemented mechanisms to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity. All CME staff and content reviewers have no relevant financial relationships with commercial interests to disclose. ACCREDITATION and CREDIT DESIGNATION: The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Yale School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.